More Turbulence for the No Surprises Act Thanks to Air Ambulance Providers

Akerman LLP - Health Law Rx
Contact

Akerman LLP - Health Law Rx

Given the trajectory, it is no longer surprising that the No Surprises Act (the Act) continues its turbulent path through implementation. The U.S. District Court for the Eastern District of Texas, on July 26, 2022, again vacated provisions of the Federal Independent Dispute Resolution (IDR) process, this time relating to air ambulance payment disputes. (LifeNet, Inc. v. United States Department of Health and Human Services, et al., No. 6:22-cv-00162-JDK, slip op. (E.D. Tex. July 26, 2022).

This week’s LifeNet decision is yet another blow to the implementation of the Act as additional portions of the interim final rule, issued pursuant to the Act (the Interim Rule), were invalidated. Relying heavily upon its prior analysis in a case brought by the Texas Medical Association (TMA) (discussed in a prior blog) concerning “a nearly identical interim final rule”, the LifeNet court held “that the [Interim] Rule conflicts with the Act and must be set aside.”

Once again, the Eastern District of Texas determined that by creating a qualifying payment amount (QPA) presumption, the Interim “Rule thus ‘places its thumb on the scale for the QPA, requiring arbitrators to presume the correctness of the QPA and then imposing a heightened burden on the remaining statutory factors to overcome that presumption.'”

In response to the LifeNet decision, CMS released a notice on July 28, 2022, that “effective July 26, 2022, certified IDR entities may not apply the vacated standard in reaching a payment determination in any payment dispute related to air ambulance services.” CMS noted that they are in the process of revising the IDR guidance in response to this case and will soon issue updates.  Also still pending, but not mentioned, is the release of CMS’ final rule, which hopefully will provide some resolution.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Akerman LLP - Health Law Rx | Attorney Advertising

Written by:

Akerman LLP - Health Law Rx
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Akerman LLP - Health Law Rx on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide